6.
Tilg H, Adolph T, Moschen A
. Multiple Parallel Hits Hypothesis in Nonalcoholic Fatty Liver Disease: Revisited After a Decade. Hepatology. 2020; 73(2):833-842.
PMC: 7898624.
DOI: 10.1002/hep.31518.
View
7.
Zhang Y, Duan X, Wassie T, Wang H, Li T, Xie C
. polysaccharide-zinc complex modulates the immune response and alleviates LPS-induced intestinal inflammation inhibiting the TLR4/NF-κB signaling pathway. Food Funct. 2021; 13(1):52-63.
DOI: 10.1039/d1fo02171k.
View
8.
Kim H, Lee D, An T, Park H, Kim W, Bae K
. Metabolic Spectrum of Liver Failure in Type 2 Diabetes and Obesity: From NAFLD to NASH to HCC. Int J Mol Sci. 2021; 22(9).
PMC: 8123490.
DOI: 10.3390/ijms22094495.
View
9.
Wang Q, Wang Z, Pang B, Zheng H, Cao Z, Feng C
. Probiotics for the improvement of metabolic profiles in patients with metabolic-associated fatty liver disease: A systematic review and meta-analysis of randomized controlled trials. Front Endocrinol (Lausanne). 2022; 13:1014670.
PMC: 9670148.
DOI: 10.3389/fendo.2022.1014670.
View
10.
Goodrich J, Waters J, Poole A, Sutter J, Koren O, Blekhman R
. Human genetics shape the gut microbiome. Cell. 2014; 159(4):789-99.
PMC: 4255478.
DOI: 10.1016/j.cell.2014.09.053.
View
11.
Campbell C, Yu R, Li F, Zhou Q, Chen D, Qi C
. Modulation of fat metabolism and gut microbiota by resveratrol on high-fat diet-induced obese mice. Diabetes Metab Syndr Obes. 2019; 12:97-107.
PMC: 6324607.
DOI: 10.2147/DMSO.S192228.
View
12.
Alcazar M, Escribano J, Ferre N, Closa-Monasterolo R, Selma-Royo M, Feliu A
. Gut microbiota is associated with metabolic health in children with obesity. Clin Nutr. 2022; 41(8):1680-1688.
DOI: 10.1016/j.clnu.2022.06.007.
View
13.
Imdad S, So B, Jang J, Park J, Lee S, Kim J
. Temporal variations in the gut microbial diversity in response to high-fat diet and exercise. Sci Rep. 2024; 14(1):3282.
PMC: 10853223.
DOI: 10.1038/s41598-024-52852-4.
View
14.
Han L, Li T, Du M, Chang R, Zhan B, Mao X
. Beneficial Effects of Bunge Water Extract on Inflammatory Cytokines Release and Gut Microbiota in High-Fat Diet and Streptozotocin-Induced Type 2 Diabetic Mice. Nutrients. 2019; 11(3).
PMC: 6470731.
DOI: 10.3390/nu11030670.
View
15.
Heiman M, Greenway F
. A healthy gastrointestinal microbiome is dependent on dietary diversity. Mol Metab. 2016; 5(5):317-320.
PMC: 4837298.
DOI: 10.1016/j.molmet.2016.02.005.
View
16.
Younossi Z, Golabi P, Paik J, Henry A, Van Dongen C, Henry L
. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology. 2023; 77(4):1335-1347.
PMC: 10026948.
DOI: 10.1097/HEP.0000000000000004.
View
17.
Belizario J, Faintuch J
. Microbiome and Gut Dysbiosis. Exp Suppl. 2018; 109:459-476.
DOI: 10.1007/978-3-319-74932-7_13.
View
18.
Cantu-Jungles T, Hamaker B
. Tuning Expectations to Reality: Don't Expect Increased Gut Microbiota Diversity with Dietary Fiber. J Nutr. 2023; 153(11):3156-3163.
DOI: 10.1016/j.tjnut.2023.09.001.
View
19.
Younossi Z, Koenig A, Abdelatif D, Fazel Y, Henry L, Wymer M
. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2015; 64(1):73-84.
DOI: 10.1002/hep.28431.
View
20.
Tilg H, Moschen A
. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology. 2010; 52(5):1836-46.
DOI: 10.1002/hep.24001.
View